Pulmatrix Q4 EPS $(0.57) Beats $(1.04) Estimate, Sales $2.20M Beat $1.77M Estimate
Pulmatrix Q4 EPS $(0.57) Beats $(1.04) Estimate, Sales $2.20M Beat $1.77M Estimate
Pulmatrix第四季度每股收益美元（0.57美元）超過預期（1.04美元），銷售額220萬美元超過177萬美元的預期
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.04) by 45.19 percent. This is a 50 percent increase over losses of $(1.14) per share from the same period last year. The company reported quarterly sales of $2.20 million which beat the analyst consensus estimate of $1.77 million by 24.41 percent. This is a 28.92 percent increase over sales of $1.71 million the same period last year.
Pulmatrix（納斯達克股票代碼：PULM）公佈的季度虧損爲每股0.57美元，比分析師普遍預期的1.04美元（1.04美元）高出45.19％。這比去年同期每股虧損1.14美元（1.14美元）增長了50％。該公司公佈的季度銷售額爲220萬美元，比分析師普遍預期的177萬美元高出24.41％。這比去年同期的171萬美元銷售額增長了28.92％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。